Application 075806
- Type
- ANDA
- Sponsor
- MYLAN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NIZATIDINE | NIZATIDINE | CAPSULE;ORAL | 150MG | No | No |
| 002 | NIZATIDINE | NIZATIDINE | CAPSULE;ORAL | 300MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075806-001 | NIZATIDINE | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | ||
| A075806-002 | NIZATIDINE | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | 2002-07-05 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | 2002-07-05 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A075806-001 | NIZATIDINE | 150MG | CAPSULE / ORAL | AB | 2002-07-05 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A075806-002 | NIZATIDINE | 300MG | CAPSULE / ORAL | AB | RS | 2002-07-05 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A075806-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A075806-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A075806-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A075806-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A075806-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A075806-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A075806-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A075806-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nizatidine | NIZATIDINE | Epic Pharma, LLC | e9957997-8b85-48a0-9bb3-b878cb223236 | 2025-01-02 | Adverse reactions | Nizatidine NIZATIDINE |
| NIZATIDINE | NIZATIDINE | Amneal Pharmaceuticals LLC | 39e62997-8781-449a-e054-00144ff88e88 | 2024-10-23 | Adverse reactions | NIZATIDINE NIZATIDINE |
| Nizatidine | NIZATIDINE | Actavis Pharma, Inc. | 367a1004-59c1-4474-a4f6-ce8bf5a1b043 | 2022-06-30 | Adverse reactions | Nizatidine NIZATIDINE |
| Nizatidine | NIZATIDINE | Dr Reddy's Laboratories Limited | faaa7cc4-fda9-d5b8-de2a-71c8744ccb76 | 2018-12-06 | Adverse reactions | Nizatidine NIZATIDINE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-5150 | Nizatidine | nizatidine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5150 | Nizatidine | nizatidine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5300 | Nizatidine | nizatidine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-5300 | Nizatidine | nizatidine | Mylan Pharmaceuticals Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 31022 | ORIG | 2004-06-10 |